Sivulle on koottu tutkimusartikkeleita eri aihealueittain. Artikkeleita voi lukea alkuperäisestä lähteestä DOI-linkkien kautta.

YHDISTELMÄVALMISTEET HYPERTENSION HOIDOSSA

Parati G ym. 2021.
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis.

Snyman J ym. 2024.
A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.

Wilke T ym. 2022.
Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study.

INDAPAMIDI

Burnier M ym. 2019.
Redefining diuretics use in hypertension: why select a thiazide-like diuretic?

STATIINI-ETSETIMIBI YHDISTELMÄHOITO

Jun JE ym. 2024.
Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular diasease and all-cause death: a propensity-matched nationwide cohort study.

Lee SJ ym. 2024.
Combination therapy with moderate-intensity atorvastatin and ezetimibe vs . high-intensity atorvastatin monotherapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability.

Leosdottir M ym. 2025.
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry.

Lewek J ym. 2023.
Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL-ACS Data.

Park JI ym. 2023.
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial.

Schubert J ym. 2024.
Intensive early and sustained lowering of non–high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.